• OPEN AN ACCOUNT
Indian Indices
Sensex
77,966.35 -187.90
( -0.24%)
Global Indices
Nasdaq
53,805.64 -191.34
(-0.35%)
Dow Jones
7,747.95 -26.16
(-0.34%)
Hang Seng
67,546.56 576.34
(0.86%)
Nikkei 225
10,849.18 -13.32
(-0.12%)
Forex
USD-INR
95.28 0.13
(0.14%)
EUR-INR
110.05 0.08
(0.07%)
GBP-INR
128.64 0.30
(0.23%)
JPY-INR
0.60 0.00
(-0.45%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3622252
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
36.02
118106.99
EPS(TTM)
Face Value()
Div & Yield %
40.59
2
0.89
 

CreditAccess Grameen consolidated net profit rises 619.23% in the March 2026 quarter
May 09,2026
Net profit of CreditAccess Grameen rose 619.23% to Rs 339.55 crore in the quarter ended March 2026 as against Rs 47.21 crore during the previous quarter ended March 2025. Sales rose 13.55% to Rs 1597.27 crore in the quarter ended March 2026 as against Rs 1406.63 crore during the previous quarter ended March 2025.

For the full year,net profit rose 46.34% to Rs 777.64 crore in the year ended March 2026 as against Rs 531.40 crore during the previous year ended March 2025. Sales rose 5.33% to Rs 6058.92 crore in the year ended March 2026 as against Rs 5752.33 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1597.271406.63 14 6058.925752.33 5
OPM %58.6938.60 -49.3847.20 -
PBDT460.6966.24 595 1096.28771.09 42
PBT445.0051.08 771 1033.20708.87 46
NP339.5547.21 619 777.64531.40 46